162 related articles for article (PubMed ID: 26503261)
21. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases.
Benech N; O'Brien JM; Barret M; Jacques J; Rahmi G; Perrod G; Hervieu V; Jaouen A; Charissoux A; Guillaud O; Legros R; Walter T; Saurin JC; Rivory J; Prat F; Lépilliez V; Ponchon T; Pioche M
United European Gastroenterol J; 2021 Apr; 9(3):362-369. PubMed ID: 32903167
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's-related neoplasia.
Podboy A; Kolahi KS; Friedland S; Louie CY
Dig Endosc; 2020 Mar; 32(3):346-354. PubMed ID: 31306525
[TBL] [Abstract][Full Text] [Related]
24. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
25. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
26. Lymph-node metastasis in surgical resection of intramucosal esophageal adenocarcinoma.
Oda I; Yamada M; Yoshinaga S; Tachimori Y; Kushima R
Dig Endosc; 2013 May; 25 Suppl 2():177-80. PubMed ID: 23617673
[TBL] [Abstract][Full Text] [Related]
27. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia.
Mandal RV; Forcione DG; Brugge WR; Nishioka NS; Mino-Kenudson M; Lauwers GY
Am J Surg Pathol; 2009 Apr; 33(4):620-5. PubMed ID: 19047893
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus.
DeMeester SR
Semin Thorac Cardiovasc Surg; 2005; 17(4):320-5. PubMed ID: 16428038
[TBL] [Abstract][Full Text] [Related]
29. Invasion of poorly differentiated adenocarcinoma to the deep muscularis mucosae may be an indicator of lymph node metastasis in Barrett's esophageal cancer.
Sakaguchi Y; Ono S; Fujishiro M; Yamamichi N; Koike K
Dig Endosc; 2013 May; 25 Suppl 2():168-72. PubMed ID: 23617671
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
Yoshii T; Ohkawa S; Tamai S; Kameda Y
Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
[TBL] [Abstract][Full Text] [Related]
32. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
Trivedi A; Cartun RW; Ligato S
Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
[TBL] [Abstract][Full Text] [Related]
33. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
34. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.
Reed CC; Shaheen NJ
J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):768-772. PubMed ID: 27541732
[TBL] [Abstract][Full Text] [Related]
36. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
von Rahden BH; Feith M; Stein HJ
Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
[TBL] [Abstract][Full Text] [Related]
37. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
DeMeester SR
Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
[No Abstract] [Full Text] [Related]
38. Lymph node metastasis in early esophageal adenocarcinoma.
Griffin SM; Burt AD; Jennings NA
Ann Surg; 2011 Nov; 254(5):731-6; discussion 736-7. PubMed ID: 21997815
[TBL] [Abstract][Full Text] [Related]
39. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
40. Esophagectomy for failed endoscopic therapy in patients with high-grade dysplasia or intramucosal carcinoma.
Hunt BM; Louie BE; Dunst CM; Lipham JC; Farivar AS; Sharata A; Aye RW
Dis Esophagus; 2014; 27(4):362-7. PubMed ID: 23795720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
